Research Topics
| Christine LebrunSummaryCountry: France Publications
| Collaborators
|
Detail Information
Publications
[Neoadjuvant chemotherapy for symptomatic non operable grade II fibrillary astrocytoma in adults]C Lebrun
Service de Neurologie, Hopital Pasteur, Nice, France
Rev Neurol (Paris) 160:533-7. 2004..All of them were seizure-free. Progression free survival was not reached at 5 Years. Up-front chemotherapy for low-grade astrocytomas may be useful and has to be prospectively evaluated...
Impact of pregnancy on conversion to clinically isolated syndrome in a radiologically isolated syndrome cohortC Lebrun
Club Francophone de Sclerose en Plaques, CHU Nice et CHU Rennes, Nice, France
Mult Scler 18:1297-302. 2012..It is unknown whether pregnancy impacts the risk of clinical conversion in those within the presymptomatic period...
Levocarnitine administration in multiple sclerosis patients with immunosuppressive therapy-induced fatigueC Lebrun
Department of Neurology, Hopital Pasteur, 30 Voie Romaine, 06002 Nice, France
Mult Scler 12:321-4. 2006..For 63% of patients treated with immunosuppressive or immunomodulatory therapies, oral levocarnitine adjunction decreased fatigue intensity, especially in patients treated with cyclophosphamide and interferon beta...
[CARIMS (Cancer Risk In Multiple Sclerosis) project: impact of long-term treatment]C Lebrun
Service de Neurologie, CHU Pasteur, Nice
Rev Neurol (Paris) 163:38-46. 2007..A prospective study is in progress in French MS centers on behalf the Club Francophone de la SEP (CARIMS Project)...
Treatment of newly diagnosed symptomatic pure low-grade oligodendrogliomas with PCV chemotherapyC Lebrun
Department of Neurology, Hopital Pasteur, Nice, France
Eur J Neurol 14:391-8. 2007..These results suggest that radiotherapy could be postponed until the malignant transformation occurs to delay cognitive side effects of irradiation...
Turcot syndrome confirmed with molecular analysisC Lebrun
Service de Neurologie, Hopital Pasteur, Nice, France
Eur J Neurol 14:470-2. 2007..The subsequent molecular characterization may contribute to the appropriate care of affected patients and asymptomatic gene carriers...
Unexpected multiple sclerosis: follow-up of 30 patients with magnetic resonance imaging and clinical conversion profileC Lebrun
Neurology, CHU de Nice, France
J Neurol Neurosurg Psychiatry 79:195-8. 2008..3 years. To our knowledge, this is the first cohort of CIS with preclinical follow-up. Early treatment should be discussed in view of the predictive value on conversion of the MRI burden of the disease...
Cancer risk and impact of disease-modifying treatments in patients with multiple sclerosisChristine Lebrun
Service de Neurologie, CHU Pasteur, 06002 Nice, France
Mult Scler 14:399-405. 2008..From 1 January 1995 to 30 June 2006, we collected and studied the profile of 7,418 MS patients gathered from nine French MS centers. We evaluated the incidence of cancer in a Cancer Risk In MS Cohort...
Impact of disease-modifying treatments in North African migrants with multiple sclerosis in FranceC Lebrun
MS Clinic, Neurology, University Hospital Pasteur, Nice, France
Mult Scler 14:933-9. 2008..0 and 6.0. We collected data and studied the impact of disease-modifying therapies (DMT) in NA patients with MS, among the 4144 MS patients treated in our MS clinics...
Successful treatment of refractory generalized myasthenia gravis with rituximabC Lebrun
Department of Neurology, Universitary Hospital, Nice, France
Eur J Neurol 16:246-50. 2009..Many therapeutic options can be ruled, such as thymectomy, corticosteroids, azathioprine, cyclophosphamide, mycophenolate mofetil, methotrexate, intravenous immunoglobulin (IVIg) or less frequently plasmapheresis must be ruled...
Association between clinical conversion to multiple sclerosis in radiologically isolated syndrome and magnetic resonance imaging, cerebrospinal fluid, and visual evoked potential: follow-up of 70 patientsChristine Lebrun
Departments of Neurology, University of Nice Sophia Antipolis, 06002 Nice, France
Arch Neurol 66:841-6. 2009..Subclinical demyelinating lesions may occur in the brains of asymptomatic individuals...
[Neurologic side effects of cytotoxic drugs]C Lebrun
Service de Neurologie, CHU de Nice, 30, avenue de la Voie Romaine, Nice Cedex, France
Rev Med Interne 31:295-304. 2010..Neuroprotective agents are still evaluated. The neurologic complications of the more commonly used chemotherapeutic agents, hormones and targeted molecular agents are discussed...
Cancer and multiple sclerosis in the era of disease-modifying treatmentsChristine Lebrun
Service de Neurologie, CHU Pasteur, 30 Voie Romaine, 06002 Nice, France
J Neurol 258:1304-11. 2011..This result could influence the attitude of the medical profession with respect to the benefit to risk ratio when proposing DMT to MS patients...
Cutaneous Side-effects of Immunomodulators in MSC Lebrun
Christine Lebrun Service de Neurologie Hopital Pasteur 30 voie romaine 06002 Nice France Tel 33 4 92 03 78 96 Fax 33 4 92 03 79 97 E mail
Int MS J 17:88-94. 2011..Non-steroid antiinflammatory gels, local corticosteroids or endermology can help patients to resolve side-effects and to continue immunomodulatory treatment...
Endermology: a treatment for injection-induced lipoatrophy in multiple sclerosis patients treated with sub cutaneous glatiramer acetateChristine Lebrun
Service de Neurologie, Hopital Pasteur, Nice, France
Clin Neurol Neurosurg 113:721-4. 2011..To evaluate sessions of endermology (LPG) on patients with lipoatrophy, due to GA injections in an open-labelled study...
[The contribution of automatic anatomical matching of sequential brain MRI scans in the monitoring of multiple sclerosis lesions]C Lebrun
Service de Neurologie, CHU, Nice
Rev Neurol (Paris) 160:805-10. 2004..There are many sources of error when comparing successive images which can be overcome to some extent with repositioning and image processing techniques...
Cognitive function in radiologically isolated syndromeChristine Lebrun
Department of Neurology of Nice University, France
Mult Scler 16:919-25. 2010..In previous studies, it was demonstrated that visual evoked potential and cerebrospinal fluid help to identify pejorative markers in converting to MS...
Acute aphasia in multiple sclerosis: A multicenter study of 22 patientsA Lacour
Department of Neurology, University of Lille, , Lille Cedex, France
Neurology 62:974-7. 2004..Brain MRI showed giant plaques in eight cases (40%). A full recovery was observed in 14 patients (64%). Furthermore, acute aphasia did not appear to be a criterion for poor prognosis...
Tear analysis in clinically isolated syndrome as new multiple sclerosis criterionGauthier Calais
Groupe Hospitalier de l Institut Catholique de Lille, Service de Neurologie, Lille, France
Mult Scler 16:87-92. 2010..We suggest that tear OCB detection may replace CSF OCB detection as a diagnostic tool in patients with CIS. This would circumvent the practice of invasive lumbar punctures currently used in MS diagnosis...
Cognitive functions in neuromyelitis opticaFrederic Blanc
Department of Neurology, Strasbourg University, Alsace, France
Arch Neurol 65:84-8. 2008..To date, cognitive functions have never been investigated in NMO...
[Turcot's syndrome confirmed by molecular biological tests]S Jeannin
Service de Neurologie, , Nice
Rev Neurol (Paris) 162:741-6. 2006..CONCLUSION: Relevant personal and familial history can provide the clue to the diagnosis of Turcot's syndrome. Molecular diagnosis may contribute to appropriate care of affected patients...
Long-term outcome of oligodendrogliomasC Lebrun
Department of Neurology, Hopital Pasteur, Nice, France
Neurology 62:1783-7. 2004..Favorable prognostic factors for oligodendroglial tumors include age younger than 40 years, low tumor grade, and extent of resection...
Rituximab in refractory and non-refractory myasthenia: a retrospective multicenter studyNicolas Collongues
Department of Neurology, University of Strasbourg, University Hospital of Hautepierre, 1 Avenue Moliere, 67000 Strasbourg, France
Muscle Nerve 46:687-91. 2012..Few data are available about the effect of rituximab (RTX) on refractory (RM) and non-refractory (NRM) myasthenia...
Increased risk of multiple sclerosis relapse after in vitro fertilisationLaure Michel
Service de Neurologie, Centre Hospitalier Universitaire de Nantes, Hopital Laennec, Nantes Cedex, France
J Neurol Neurosurg Psychiatry 83:796-802. 2012..The objective of this study was to determine if there was an increased risk of developing exacerbations in women with MS after in vitro fertilisation (IVF)...
[Natalizumab (Tysabri) prescription practices of neurologists in southern France]F Rocher
Service de Neurologie, Hopital Pasteur, CHU de Nice, 30 Venue de la Voie Romaine, BP 69, 06002 Nice Cedex 01, France
Rev Neurol (Paris) 166:412-8. 2010....
[Diagnostic and prognostic values of 1p and 19q deletions in adult gliomas: critical review of the literature and implications in daily clinical practice]D Fontaine
Service de Neurochirurgie, Hopital Pasteur, CHU de Nice, UNSA, 30, avenue de la Voie Romaine, 06000 Nice, France
Rev Neurol (Paris) 164:595-604. 2008....
Auto-immune cerebellar ataxia with anti-GAD antibodies accompanied by de novo late-onset type 1 diabetes mellitusC Bayreuther
Neurology Department, Pasteur Hospital, 30, Voie Romaine, 06002 Nice, France
Diabetes Metab 34:386-8. 2008..In addition, a few patients with progressive cerebellar ataxia show high titres of GAD-Ab, suggesting an auto-immune origin...
[Mills' syndrome: a rare clinical entity]S Lachaud
Service d EFSN, Hopital Pasteur, Nice, France
Rev Neurol (Paris) 163:335-40. 2007..This syndrome is of uncertain nosological status, and is supposedly due to unilateral primary degeneration of corticospinal pathway. Some authors have suggested that it could represent a variant of primary lateral sclerosis...
[Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis]M N Magnie
Service d Explorations Fonctionnelles du Système Nerveux, CHU de Nice
Rev Neurol (Paris) 163:1065-74. 2007....
[Depression in multiple sclerosis]C Lebrun
Service de Neurologie, Hopital Pasteur, Nice
Rev Neurol (Paris) 165:S156-62. 2009..MS patients respond well to treatment, either psychotherapy or antidepressants...
[De Seze et al. criteria: application to a series of 14 patients presenting a first severe acute demyelinating event]E Bozzolo
Service de Neurologie, Pavillon F, CHU de Nice, Hopital Pasteur, 30, avenue de la Voie Romaine, BP 69, 06002 Nice cedex 1, France
Rev Neurol (Paris) 165:38-47. 2009..We applied these criteria to 14 patients who presented a first severe acute demyelinating event and whose later clinical course enabled clear identification of the neurological diagnosis...
[Phenotypical aspects and clinical course of multiple sclerosis in 76 patients with a North African ethnic background followed at the Nice University Hospital]S Jeannin
Service de Neurologie, CHRU Nice, Hopital Pasteur, 30 Voie Romaine, Nice
Rev Neurol (Paris) 163:440-7. 2007..In the European multiple sclerosis (MS) database registered in Nice, about 8p.cent of the patients have a North African ethnic background...
[Chorea-acanthocytosis without acanthocytes]C Bayreuther
Service de Neurologie, Hopital Pasteur, CHU de Nice, 30, Voie Romaine, 06002 Nice, France
Rev Neurol (Paris) 166:100-3. 2010..ChAc patients exhibit involuntary movements, psychiatric abnormalities and progressive cognitive deterioration. We report a case of ChAc in which blood smears failed to demonstrate acanthocytes...
Treatment of progressive forms of multiple sclerosis by cyclophosphamide: a cohort study of 490 patientsH Zephir
Department of Neurology, , CHRU of Lille, 59037, Lille, Cedex, France
J Neurol Sci 218:73-7. 2004..To date, no treatment is approved for PPMS and we therefore propose a trial to test the use of CYC treatment early in the course of the disease in PPMS patients with disability progression...
More severe disability of North Africans vs Europeans with multiple sclerosis in FranceM Debouverie
Department of Neurology, Central Hospital, Nancy, France
Neurology 68:29-32. 2007..To compare the clinical disease progression in European (E) and North African (NA) patients with multiple sclerosis (MS) patients in France...
[Longitudinal study of health related quality of life in multiple sclerosis: correlation with MRI parameters]M Cohen
Service de Neurologie, Hopital Pasteur, CHU de Nice, 30, Voie Romaine, BP69, 06002 Nice Cedex, France
Rev Neurol (Paris) 166:894-900. 2010..Health related quality of life (HRQOL) is often affected in multiple sclerosis (MS). Nevertheless, to our knowledge, there is no longitudinal study in the literature about the correlation between MRI parameters and HRQOL in MS patients...
[Relapsing remitting multiple sclerosis or multiphasic disseminated encephalomyelitis?]C Lebrun
Service de Neurologie, Hopital Pasteur, CHU de Nice, 06002 Nice
Rev Neurol (Paris) 161:228-33. 2005..In patients with a history of recent infection or vaccination, especially for adolescents or young adults, the differential diagnosis with acute disseminated encephalomyelitis can be difficult...
Nitroso-urea-cisplatin-based chemotherapy associated with valproate: increase of haematologic toxicityV Bourg
Service de Neurologie, H pital Pasteur, Nice, France
Ann Oncol 12:217-9. 2001..Haematologic side-effects decrease after AED modification during the continued chemotherapy. This adverse event should be managed with caution...
[Treatment of progressive multiple sclerosis with monthly pulsed cyclophosphamide-methylprednisolone: predictive factors of treatment response]E Delmont
Service de Neurologie, CHU de Nice
Rev Neurol (Paris) 160:659-65. 2004..CONCLUSION: Cyclophosphamide appears to be more efficient in early stage of progressive multiple sclerosis independently of age, relapses or neurological disability scale...
[Therapeutic indications in symptomatic cognitive and psychopathological disorders in multiple sclerosis]C Lebrun
Service de Neurologie, , 30, Voie Romaine, BP69, 06002 Nice
Rev Neurol (Paris) 157:1085-90. 2001..Depressive states are twice frequent and usual antidepressant drugs seems to demonstrate some efficacy...
Idiopathic acute transverse myelitis: application of the recent diagnostic criteriaJ de Seze
Department of Neurology, University of Lille, France
Neurology 65:1950-3. 2005..In a retrospective study of 288 patients with ATM, 45 cases (15.6%) met the criteria for idiopathic ATM. The patients formed a relatively homogeneous group in terms of clinical and MRI data, but the prognosis was highly variable...
[Early detection of cognitive impairment in relapsing-remitting multiple sclerosis: functional-anatomical correlations and longitudinal follow-up]C Bensa
Service de Neurologie, , CHU Nice
Rev Neurol (Paris) 162:1221-31. 2006..CONCLUSION: During the initial phase of the disease, most of the relapsing remitting patients present a mild cognitive impairment. Early detection, therapeutic propositions, and recognition of disorders are necessary...
[Chemotherapeutic neurotoxicity]C Lebrun
Service de Neurologie, CHU de Nice
Rev Neurol (Paris) 159:741-54. 2003..It points out the need for continuous clinical evaluation to detect their appearance. When neurological complications are diagnosed late, they are rarely reversible. Neuroprotective agents are still under evaluation...
[Neurosarcoidosis treated with mycophenolate mofetil: two cases]A Chaussenot
Service de Neurologie, Hopital Pasteur, Nice
Rev Neurol (Paris) 163:471-5. 2007..MMF is efficient and well tolerated, but there is no case-report about neurosarcoidosis...
First-line nitrosourea-based chemotherapy in symptomatic non-resectable supratentorial pure low-grade astrocytomasM P Frenay
Service de Neurologie, , Nice, France
Eur J Neurol 12:685-90. 2005..This report suggests that benefits of CT on symptoms, survival, and quality of life should be prospectively compared with RT...
[Intravenous immunoglobulins for relapsing-remitting multiple sclerosis after failure of treatment with other immuno-modulators]C Lebrun
Service de Neurologie, , Nice, France
Rev Neurol (Paris) 159:648-51. 2003..Surprisingly, some patients had partial improvement of neurological functions which were considered as sequelae. Indications for intravenous immunoglobulins in the treatment of the multiple sclerosis need to be evaluated...
Immunosuppressive therapy is more effective than interferon in neuromyelitis opticaC Papeix
Department of Neurology, Hopital de la Salpetriere, Paris, France
Mult Scler 13:256-9. 2007..The probability of relapse was significantly lower in the IS Group (P =0.0007). From our results, interferon beta is not recommended, and one of the best current therapeutic options for NMO appears to be immunosuppressants...
Is Devic's neuromyelitis optica a separate disease? A comparative study with multiple sclerosisJ de Seze
Department of Neurology, Hopital R Salengro, University of Lille, France
Mult Scler 9:521-5. 2003..The respective criteria for NMO and MS were able to distinguish these two pathologies but only when MRI data were applied. This finding could have implications for future therapeutic trials...
[Recurrent aseptic meningitis associated with primary biliary cirrhosis.]C Bensa
Service de Neurologie, , Nice
Rev Neurol (Paris) 161:87-91. 2005..To our knowledge, this is the first case reported in literature...
[Beta-interferon clinical trials using MRI in patients with multiple sclerosis]C Lebrun
Service de Neurologie, , 30, Voie Romaine, BP 69, 06002 Nice Cedex, France
Rev Neurol (Paris) 157:761-7. 2001..We reviewed the correlations between the radiological and clinical findings and the methodology of published trials on beta interferons in remitting, secondarily progressive and early onset multiple sclerosis...
[Late cerebellar ataxia associated with fragile X premutation]A Chaussenot
Service de Neurologie, Hopital Pasteur, 30, Voie Romaine, 06002, Nice, France
Rev Neurol (Paris) 164:957-63. 2008..We report a case of FXTAS with isolated cerebellar ataxia...
Antibodies to the extracellular receptor domain restore the hormone-insensitive kinase and conformation of the mutant insulin receptor valine 382C Lebrun
Institut National de la Sante et de la Recherche Medicale, Unité 145, Faculte de Medecine, Nice, France
J Biol Chem 268:11272-7. 1993..ii) Ligands other than insulin, such as antibodies, which perturb the extracellular domain, can function as alternative ways to restore the mutant receptor kinase...
[Therapeutic indications in spasticity symptoms of multiple sclerosis]C Lebrun
Service de Neurologie, , 30 Voie Romaine, BP69, 06002 Nice
Rev Neurol (Paris) 157:1045-50. 2001..A variety of oral and parenteral medications are available. Review of comparative efficacy and tolerability of anti-spastic agents is performed in order to guide rational prescribing...
[Evolution of antibiotic resistance and serogroups of Streptococcus pneumoniae over the 1997-2003 period in Brittany]S Mignard
Département de Bactériologie Virologie et Hygiène Hospitalière, CHU, 35033 Rennes, France
Pathol Biol (Paris) 53:457-62. 2005..Future surveillance after vaccination will be needed to detect emerging serogroups and resistance among S. pneumoniae...
Nonconvulsive status epilepticus of frontal originP Thomas
Service de Neurologie, Hopital Pasteur, Nice, France
Neurology 52:1174-83. 1999..To determine the electroclinical characteristics and causative factors of nonconvulsive status epilepticus (NCSE) of frontal origin...
[Therapeutic indications in symptoms of bladder and sphincter disorders in multiple sclerosis]C Lebrun
Service de Neurologie, , 30, Voie Romaine, BP69, 06002 Nice
Rev Neurol (Paris) 157:1060-5. 2001..Intermittent catheterization, surgical treatment, or electrostimulation are proposed in most severe cases. Therapies for intestinal disorders are more limited. Management of symptoms and different therapies are reviewed...
[Acute polyradiculoneuritis and dysautonomia: contribution of assaying catecholamines and their methoxylated metabolites]C Lebrun
Service de Neurologie, Hopital Pasteur, Nice Cedex, France
Rev Neurol (Paris) 157:304-8. 2001..The elevated level of urinary methoxylated metabolites is statistically correlated to clinical dysautonomia and can be used as a biological marker to monitoring demyelinating polyradiculoneuritis...
Acute fulminant demyelinating disease: a descriptive study of 60 patientsJerome De Seze
Departement de Neurologie, Hopital Civil, 1 Place de l Hopital, BP 426, 67091 Strasbourg Cedex, France
Arch Neurol 64:1426-32. 2007..To date, no clear criteria exist for ADEM, and the risk of subsequent evolution to multiple sclerosis (MS) remains unknown...
